Skip to content
HowShorted

How shorted is Enliven Therapeutics, Inc.? ELVN

#504most shorted US stockof 3,805 ranked stocks, more shorted than 86%

11.77%
of shares outstanding reported short · settlement date 15 Sep 2026
vs previous report
+0.03
5 reports (~10 weeks)
−2.23
days to cover
9.01
Aggregate net short position time series for Enliven Therapeutics, Inc.

Markers along the chart's base: ▲ results announced (an 8-K reporting results was filed) ▲ quarterly or annual report filed. Dates are SEC filing dates; hover a point to see events since the previous settlement.

Days to cover

FINRA's own figure: reported shares short divided by the stock's average daily trading volume, published alongside each settlement. It expresses the short position in days of typical trading rather than as a percentage of the company; the two can move differently.

Aggregate net short position time series for Enliven Therapeutics, Inc. days to cover

Short interest around results

For each results announcement (an 8-K reporting results, by its SEC filing date), the FINRA settlement before it and the first one after. Settlements fall twice a month, so the two figures can sit up to a month apart and much else changes in between: this shows what was reported, not why.

Reported short interest before and after each results announcement
Results filedSettlement beforeSettlement afterChange
5 Aug 202611.13% 31 Jul 202611.27% 14 Aug 2026+0.14
7 May 20268.66% 30 Apr 20268.41% 15 May 2026−0.25
3 Mar 202613.45% 27 Feb 202613.84% 13 Mar 2026+0.39
12 Nov 202513.11% 31 Oct 202513.13% 14 Nov 2025+0.02
13 Aug 20258.57% 31 Jul 20258.35% 15 Aug 2025−0.22
14 May 202514.25% 30 Apr 202513.32% 15 May 2025−0.93
13 Mar 202515.09% 28 Feb 202515.01% 14 Mar 2025−0.08
13 Nov 202414.62% 31 Oct 202414.46% 15 Nov 2024−0.16

Fails to deliver

The SEC's fails-to-deliver figure for ELVN: the aggregate net balance of shares that failed to be delivered at each settlement date, published by the SEC twice a month and shown here verbatim for the trailing window. A balance is not a daily flow, and a fail has many ordinary causes; the SEC says it cannot guarantee the accuracy of the data. See what fails to deliver are and the largest balances today.

Last balance on file
31
11 Sep 2026
Highest in window
298,601
9 Jan 2026
Days with a balance
86
Window
16 Sep 2025 to 14 Sep 2026
Aggregate net short position time series for Enliven Therapeutics, Inc. fails to deliver

Source: U.S. Securities and Exchange Commission, fails-to-deliver data (public domain). Only settlement days with a positive balance appear; the largest balance in the window was 299K shares.

Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Download chart cardShare on XRedditLinkedIn
Cite this page
Plain
Wikipedia
BibTeX

Sector: Healthcare

History

Full reported short interest history
Settlement dateShort %Change
15 Sep 202611.77%+0.03
31 Aug 202611.74%+0.47
14 Aug 202611.27%+0.14
31 Jul 202611.13%−3.08
15 Jul 202614.21%+0.21
30 Jun 202614.00%+5.09
15 Jun 20268.91%+0.35
29 May 20268.56%+0.15
15 May 20268.41%−0.25
30 Apr 20268.66%−0.40
15 Apr 20269.06%−1.14
31 Mar 202610.20%−3.64
13 Mar 202613.84%+0.39
27 Feb 202613.45%−0.16
13 Feb 202613.61%+0.35
30 Jan 202613.26%−2.19
15 Jan 202615.45%+1.44
31 Dec 202514.01%+0.34
15 Dec 202513.67%+0.20
28 Nov 202513.47%+0.34
14 Nov 202513.13%+0.02
31 Oct 202513.11%+2.27
15 Oct 202510.84%+1.22
30 Sep 20259.62%+1.42
15 Sep 20258.20%−0.06
29 Aug 20258.26%−0.09
15 Aug 20258.35%−0.22
31 Jul 20258.57%−2.73
15 Jul 202511.30%−1.20
30 Jun 202512.50%−0.99
13 Jun 202513.49%+0.24
30 May 202513.25%−0.07
15 May 202513.32%−0.93
30 Apr 202514.25%−0.98
15 Apr 202515.23%+0.36
31 Mar 202514.87%−0.14
14 Mar 202515.01%−0.08
28 Feb 202515.09%−0.14
14 Feb 202515.23%+0.68
31 Jan 202514.55%+0.03
15 Jan 202514.52%+0.34
31 Dec 202414.18%+0.11
13 Dec 202414.07%−0.07
29 Nov 202414.14%−0.32
15 Nov 202414.46%−0.16
31 Oct 202414.62%+0.83
15 Oct 202413.79%+0.87
30 Sep 202412.92%+1.21
13 Sep 202411.71%+0.39
30 Aug 202411.32%+0.06
15 Aug 202411.26%−1.57
31 Jul 202412.83%+0.14
15 Jul 202412.69%−1.48
28 Jun 202414.17%+0.75
14 Jun 202413.42%+0.27
31 May 202413.15%+0.32
15 May 202412.83%+1.39
30 Apr 202411.44%+0.22
15 Apr 202411.22%+0.98
28 Mar 202410.24%−0.23
15 Mar 202410.47%−0.05
29 Feb 202410.52%−1.38
15 Feb 202411.90%−0.62
31 Jan 202412.52%+0.01
12 Jan 202412.51%−0.86
29 Dec 202313.37%+0.49
15 Dec 202312.88%+0.17
30 Nov 202312.71%+0.05
15 Nov 202312.66%+0.10
31 Oct 202312.56%+0.16
13 Oct 202312.40%−0.07
29 Sep 202312.47%−0.08
15 Sep 202312.55%+0.10
31 Aug 202312.45%−0.44
15 Aug 202312.89%−0.14
31 Jul 202313.03%−0.15
14 Jul 202313.18%+0.17
30 Jun 202313.01%+3.71
15 Jun 20239.30%+2.10
31 May 20237.20%+0.60
15 May 20236.60%+5.36
15 Feb 20231.24%−3.96
30 Dec 20225.20%−0.14
15 Dec 20225.34%−0.47
30 Nov 20225.81%−0.43
15 Nov 20226.24%−0.69
31 Oct 20226.93%+5.21
31 Aug 20221.72%+0.99
15 Aug 20220.73%+0.24
29 Jul 20220.49%+0.17
15 Jul 20220.32%−0.21
30 Jun 20220.53%0.00
15 Jun 20220.53%−0.16
31 May 20220.69%−0.05
13 May 20220.74%+0.39
14 Apr 20220.35%−0.11
31 Mar 20220.46%+0.16
15 Mar 20220.30%0.00
15 Feb 20220.30%−0.09
31 Jan 20220.39%+0.06
14 Jan 20220.33%+0.03
31 Dec 20210.30%−0.27
15 Dec 20210.57%+0.04
30 Nov 20210.53%+0.16
15 Nov 20210.37%+0.02
29 Oct 20210.35%−0.12
15 Oct 20210.47%+0.07
30 Sep 20210.40%+0.04
15 Sep 20210.36%−0.07
31 Aug 20210.43%0.00
13 Aug 20210.43%−1.72
15 Jul 20212.15%−1.18
30 Jun 20213.33%−1.47
15 Jun 20214.80%+0.22
28 May 20214.58%−0.03
14 May 20214.61%+0.14
30 Apr 20214.47%+0.33
15 Apr 20214.14%+0.66
31 Mar 20213.48%+0.17
15 Mar 20213.31%−0.81
26 Feb 20214.12%+0.10
12 Feb 20214.02%+0.13
29 Jan 20213.89%+0.32
15 Jan 20213.57%+0.59
31 Dec 20202.98%+0.26
15 Dec 20202.72%−0.11
30 Nov 20202.83%+0.15
13 Nov 20202.68%+0.09
30 Oct 20202.59%−0.06
15 Oct 20202.65%+0.68
30 Sep 20201.97%+0.46
15 Sep 20201.51%−0.16
31 Aug 20201.67%+0.85
14 Aug 20200.82%+0.08
31 Jul 20200.74%−0.04
15 Jul 20200.78%–

Newest first. Scroll inside the table for earlier dates, back to 15 Jul 2020.

Frequently asked questions

How shorted is Enliven Therapeutics, Inc. right now?
11.77% of Enliven Therapeutics, Inc.'s (ELVN) shares outstanding were reported short for settlement date 15 Sep 2026, per FINRA's consolidated short interest report. That makes it the 504th most shorted US stock, out of 3,805 we rank.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Is this ELVN's short float?
No. This is short interest as a percentage of shares outstanding, the count in the company's SEC filings. "Short float" divides the same FINRA short count by the public float, which excludes closely held shares, so it comes out higher for the same company. We publish no float estimates: the float is not a regulatory figure.
What is ELVN's days to cover?
9.01 days for settlement date 15 Sep 2026: FINRA's own short interest ratio, the reported shares short divided by average daily trading volume. It is published in the same FINRA file and shown verbatim; we hold no volume data ourselves.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.